• Explore /
  • Poster
  • / Randomized phase III study of gemcitabine and cisplatin (GC) versus dose dense methotrexate, vinblastine, doxorubicin and cisplatin (DD-MVAC) in the perioperative setting for patients with locally advanced transitional cell cancer of the bladder: The French GETUG/AFU V05 VESPER trial.

Randomized phase III study of gemcitabine and cisplatin (GC) versus dose dense methotrexate, vinblastine, doxorubicin and cisplatin (DD-MVAC) in the perioperative setting for patients with locally advanced transitional cell cancer of the bladder: The French GETUG/AFU V05 VESPER trial.

Abstract Poster

Authors

null

Christian Pfister

Centre Hospitalier de Rouen, Rouen, France

Christian Pfister , Gwenaelle Gravis , Geraldine Pignot , Aude Flechon , Michel Soulie , Christine Chevreau , Laurent Guy , Brigitte Laguerre , Nicolas Mottet , Florence Joly , Michel Henry-Amar , Francois Radvanyi , Yves Allory , Stephane Culine

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Urothelial Carcinoma

Clinical Trial Registration Number

NCT 018 12369

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr TPS530)

DOI

10.1200/JCO.2018.36.6_suppl.TPS530

Abstract #

TPS530

Poster Bd #

N8

Abstract Disclosures

Similar Posters

First Author: Hiroshi Kitamura

First Author: Srikala S. Sridhar

First Author: Benjamin Miron

First Author: Jonathan Lawrence Wright